Ads by Google
62-year-old Luther Roden is the first in east Texas to benefit from a heart bypass procedure done totally endoscopically using the da Vinci Robotic Surgical System.
Cardica presented data evaluating the patency, or openness, of bypass grafts connecting the internal mammary artery to the left anterior descending artery using the C-Port xA or Flex A Distal Anastomosis Systems.
Synvista Therapeutics announced dosing of the first patient in BENEFICIAL trial, a novel compound designed to act as an AGE-cross-link breaker, in patients with chronic heart failure.
Investigational agent of Astellas Pharma US vernakalant hydrochloride increased conversion to normal heart rhythm in patients with atrial fibrillation.
People with diabetes who have asymptomatic heart disease may be able to vastly improve the flow of blood to their hearts without surgical intervention.
Nile Therapeutics announced results from a Phase 1a clinical study of CD-NP, Nile's selective NPR-B agonist being developed for the treatment of heart failure. The results of this study will be included in the Company's presentation today at the BIO Investor Forum in San Francisco, CA.
Astellas Pharma announced that the investigational agent vernakalant hydrochloride increased conversion to normal heart rhythm.
World Heart Day urges parents to set a good example and ensure that children adopt healthy-heart habits early in life.
Older women who experience at least one full-blown panic attack may have an increased risk of having a heart attack or stroke and an increased risk of death in the next five years.
Women and blacks are less likely than white men to receive implantable heart defibrillators.
Clinical trials show that ICDs (implantable cardioverter-defibrillator) save lives, so the sex difference in treatment rates is worrisome.
Many Americans hospitalized for heart failure are coming up short when it comes to getting the therapy they need - especially women and minorities.
Signalife has completed in-house testing and technological evaluation of various new modules for its holter and intra- cardiac monitors - items.
A new PBS series from filmmaker David Grubin - The Mysterious Human Heart - that explores the body's perpetual motion machine and how we cope with coronary diseases, to premier October 15, 2007.
Infants and children receiving artificial heart-valve replacements face several repeat operations as they grow, since the replacements become too small and must be traded for bigger ones. Researchers at Children's Hospital Boston have now developed a solution: living, growing valves created in the lab from a patient's own cells.
A new book of pocket-charts that will help health workers to identify people at risk of heart attacks and strokes.
Global Cardio Care Centers and its board-certified cardiologists and internal medicine physicians deliver pioneering enhanced external counterpulsation, or EECP providing FDA-approved treatment is first and foremost for people with congestive heart failure, coronary artery disease and angina.
Researchers said that women with heart conditions might need different treatments than men.